NCT06192706 is a NA clinical trial of Foldax Tria Aortic Valve in Aortic Valve Stenosis, sponsored by Foldax, Inc.

Who is sponsoring NCT06192706?

NCT06192706 is sponsored by Foldax, Inc.

What drugs are being tested in NCT06192706?

Interventions in NCT06192706: Foldax Tria Aortic Valve.

What condition does NCT06192706 study?

NCT06192706 studies Aortic Valve Stenosis, Aortic Valve Insufficiency, Aortic Valve Calcification, Aortic Valve Disease.

Is NCT06192706 still recruiting?

NCT06192706 is currently status unknown. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT06192706

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Investigation for the Foldax Tria Aortic Heart Valve- India

Status unknown NA Last updated 5 January 2024

What this trial tests

NA trial testing Foldax Tria Aortic Valve in Aortic Valve Stenosis in 50 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 July 2024

1 September 2024

Quick facts

Lead sponsor	Foldax, Inc
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 January 2022
Primary completion	1 July 2024
Estimated completion	1 September 2024
Sites	10 locations across India

Drugs / interventions tested

Foldax Tria Aortic Valve

Conditions studied

Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
Aortic Valve Insufficiency — all drugs for Aortic Valve Insufficiency →
Aortic Valve Calcification — all drugs for Aortic Valve Calcification →
Aortic Valve Disease — all drugs for Aortic Valve Disease →

Sponsor

Foldax, Inc

Who can join

45 and older, any sex, with Aortic Valve Stenosis or Aortic Valve Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to conduct a clinical investigation of the Foldax Tria Aortic Valve to collect evidence on the device's safety and performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Valve Stenosis

Currently open trials in the same condition.

NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting

Other Foldax, Inc trials

Trials by the same sponsor.

NCT06191718 — Clinical Investigation for the Foldax Tria Mitral Valve- India · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06192706 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Foldax, Inc
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06192706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing